Assessment of CD133-positive extracellular membrane vesicles in pancreatic cancer ascites and beyond

[1]  H. Koga,et al.  Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer , 2019, Medical Molecular Morphology.

[2]  Yuanyan Wei,et al.  Monoubiquitination of Cancer Stem Cell Marker CD133 at Lysine 848 Regulates Its Secretion and Promotes Cell Migration , 2018, Molecular and Cellular Biology.

[3]  R. Alessandro,et al.  The HDAC6 Inhibitor Tubacin Induces Release of CD133+ Extracellular Vesicles From Cancer Cells , 2017, Journal of cellular biochemistry.

[4]  S. Kloska,et al.  CD133-Positive Membrane Particles in Cerebrospinal Fluid of Patients with Inflammatory and Degenerative Neurological Diseases , 2017, Front. Cell. Neurosci..

[5]  W. Huttner,et al.  Monoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133) , 2016, PloS one.

[6]  Jah-yao Liu,et al.  A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers , 2016, Oncotarget.

[7]  M. Zöller,et al.  Pancreatic cancer stem cell markers and exosomes - the incentive push. , 2016, World journal of gastroenterology.

[8]  C. Théry,et al.  Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes , 2016, Proceedings of the National Academy of Sciences.

[9]  W. Huttner,et al.  Human Prominin-1 (CD133) Is Detected in Both Neoplastic and Non-Neoplastic Salivary Gland Diseases and Released into Saliva in a Ubiquitinated Form , 2014, PloS one.

[10]  D. Corbeil,et al.  Wnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells. , 2013, Experimental cell research.

[11]  W. Huttner,et al.  Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles—a role of the endocytic–exocytic pathway , 2011, EMBO molecular medicine.

[12]  Yuanyan Wei,et al.  Alpha2,3-Sialylation regulates the stability of stem cell marker CD133. , 2010, Journal of biochemistry.

[13]  D. Gingras,et al.  The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases. , 2009, Biochemistry.

[14]  W. Huttner,et al.  The Stem Cell Marker CD133 (Prominin-1) Is Expressed in Various Human Glandular Epithelia , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[15]  S. Bidlingmaier,et al.  The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells , 2008, Journal of Molecular Medicine.

[16]  W. Hacke,et al.  The Stem Cell Marker Prominin‐1/CD133 on Membrane Particles in Human Cerebrospinal Fluid Offers Novel Approaches for Studying Central Nervous System Disease , 2008, Stem cells.

[17]  A. Molven,et al.  Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas , 2008, BMC Cancer.

[18]  W. Huttner,et al.  Stem Cell Marker Prominin-1/AC133 Is Expressed in Duct Cells of the Adult Human Pancreas , 2008, Pancreas.

[19]  C. Heeschen,et al.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.

[20]  W. Huttner,et al.  Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells , 2005, Journal of Cell Science.

[21]  H. Frank,et al.  Monoclonal Antibody CD133–2 (AC141) Against Hematopoietic Stem Cell Antigen CD133 Shows Crossreactivity with Cytokeratin 18 , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[22]  W. Huttner,et al.  The Human AC133 Hematopoietic Stem Cell Antigen Is also Expressed in Epithelial Cells and Targeted to Plasma Membrane Protrusions* , 2000, The Journal of Biological Chemistry.

[23]  R. Warnke,et al.  A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. , 1997, Blood.

[24]  A. Marzesco.  Prominin-1-containing membrane vesicles: origins, formation, and utility. , 2013, Advances in experimental medicine and biology.

[25]  D. Corbeil,et al.  Prominin-1 (CD133): Molecular and Cellular Features Across Species. , 2013, Advances in experimental medicine and biology.

[26]  W. Huttner,et al.  Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer , 2004, Cell and Tissue Research.